# Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT

> **NCT00709592** · PHASE2 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 42 (actual)

## Conditions studied

- Non-Hodgkin's Lymphoma
- Leukemia
- Multiple Myeloma
- Acute Myeloid Leukemia
- Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Myelodysplastic Syndrome

## Interventions

- **BIOLOGICAL:** Thymoglobulin
- **RADIATION:** Total-Body Irradiation
- **PROCEDURE:** Allogeneic PBSCT or BMT
- **DRUG:** Tacrolimus
- **DRUG:** Mycophenolate Mofetil

## Key facts

- **NCT ID:** NCT00709592
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07-21
- **Primary completion:** 2014-02-15
- **Final completion:** 2017-06-28
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2018-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00709592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00709592, "Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00709592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*